News
Media
Medical World NewsPodcastsVideosInsightsPeer ExchangeMedia DayNews NetworkRoundtables
Conference
Conference CoverageConference Listing
Publication
More
CME/CE
Partners
Resources
Interactive ToolsSpecial ProjectsSponsored
Contribute
Case StudiesWriters and Mentors
Clinical Forum Insights

Subscribe

  • News
  • Media
  • Conference
  • Publication
  • CME/CE
  • Partners
  • Resources
  • Contribute
  • Subscribe
  • Clinical Forum Insights
  • Antimicrobial Stewardship
  • Blood-Borne Diseases
    • Ebola
    • HCV / Hepatitis
  • Coronavirus / COVID
  • Food Borne Infection / Food Safety
    • E. Coli
    • Food Safety
    • Listeria
    • Salmonella
  • Fungal Infections
    • Candida auris
  • Gastrointestinal Infections
    • C. Difficile
    • H. Pylori
    • Norovirus
  • Healthcare Associated Infections (HAI)
  • Prevention
    • Antibiotics
    • Immunizations
    • Vaccines
  • Respiratory Infections
    • Community-Acquired Pneumonia
    • Measles
    • Influenza
  • Sexually Transmitted Diseases
    • HIV / AIDS
    • HPV
    • HSV
    • PrEP
  • Skin & Soft Tissue Diseases
    • MRSA
  • Zoonotic & Vector-Borne Diseases
    • Lyme Disease
    • ZIKA
Spotlight -
Antimicrobial Stewardship|
Bench to Bedside With SIDP|
C. difficile |
Clinical Corner|
Fungal Infections|
Hepatitis|
RSV: A New Era in Prevention
Advertisement

RYAN W. STEVENS, PHARMD, BCIDP, BCPS

Advertisement

Articles by RYAN W. STEVENS, PHARMD, BCIDP, BCPS

Exploring Primary Prophylaxis for Invasive Pulmonary Aspergillosis

ByRYAN W. STEVENS, PHARMD, BCIDP, BCPS,KAITE KAMMERS, PHARMD, BCPS
December 11th 2018

Invasive aspergillosis affects up to 13% of immunocompromised patients who are in the hospital.

Advertisement

Latest Updated Articles

  • Exploring Primary Prophylaxis for Invasive Pulmonary Aspergillosis
    Exploring Primary Prophylaxis for Invasive Pulmonary Aspergillosis

    Published: December 11th 2018 | Updated:



Advertisement
Advertisement

Trending on Contagion Live

1

Top Infectious Disease News Stories Week of January 3 - January 9

2

Unlocking New Defenses: The Changing Landscape of Candida auris Management

3

COVID-19: The Gaps in Science Communication

4

What's New in 2025: From the CLSI Subcommittee on Antimicrobial Susceptibility Testing

5

Training Healthcare Professionals to Treat High-Consequence Infectious Disease

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Do Not Sell My Information
  • Privacy
  • Terms & Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us